Skip to main content
. 2022 Nov 2;110(1):76–83. doi: 10.1093/bjs/znac352

Table 1.

Selection criteria for low-risk patients included in the best-patient-in-best-centre benchmark analysis

Inclusion criteria
 Age ≥18 years
 Minimally invasive spleen-preserving distal pancreatectomy  for benign and premalignant lesions
Exclusion criteria: surgical
 Extended distal pancreatectomy or multivisceral resection
 Previous major abdominal surgery (bariatric and liver surgery)
Exclusion criteria: co-morbidities
 ASA fitness grade ≥ III
 BMI ≥ 35 kg/m²
 Cardiac disease, defined as:
  CHF onset or exacerbation in the 30 days before surgery
  History of angina pectoris within 1 month of surgery
  Myocardial infarct within 6 months of surgery
  History of percutaneous coronary intervention or cardiac surgery
  Atrial fibrillation
 Chronic renal failure (MDRD ≥ stage 3), defined as:
  GFR < 60 ml per min per 1.73 m2, or serum creatinine >1.8 mg/dl or 160 μmol/l
 Chronic obstructive pulmonary disease with FEV1 < 80%
Exclusion criteria: medication
 Use of one of the following anticoagulants:
  Non-vitamin K antagonist oral anticoagulants
  Vitamin K antagonist
  Clopidogrel
 ≥ 2 oral antidiabetic drugs or insulin

ASA, American Society of Anaesthesiologists; BMI, body mass index; CHF, congestive heart failure; MDRD, Modification of Diet in Renal Disease; GFR, glomerular filtration rate; FEV1, forced expiratory volume in 1 second.